Non-epigenetic function of HDAC8 in regulating breast cancer stem cells by maintaining Notch1 protein stability

Min Wu Chao, Po Chen Chu, Hsiao Ching Chuang, Fang Hsiu Shen, Chih Chien Chou, En Chi Hsu, Lauren E. Himmel, Han Li Huang, Huang Ju Tu, Samuel K. Kulp, Che Ming Teng, Ching Shih Chen

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Here, we report a novel non-epigenetic function of histone deacetylase (HDAC) 8 in activating cancer stem cell (CSC)-like properties in breast cancer cells by enhancing the stability of Notch1 protein. The pan-HDAC inhibitors AR-42 and SAHA, and the class I HDAC inhibitor depsipeptide, suppressed mammosphere formation and other CSC markers by reducing Notch1 expression in MDA-MB-231 and SUM-159 cells. Interrogation of individual class I isoforms (HDAC1-3 and 8) using si/shRNAmediated knockdown, ectopic expression and/or pharmacological inhibition revealed HDAC8 to be the primary mediator of this drug effect. This suppression of Notch1 in response to HDAC8 inhibition was abrogated by the proteasome inhibitor MG132 and siRNA-induced silencing of Fbwx7, indicating Notch1 suppression occurred through proteasomal degradation. However, co-immunoprecipitation analysis indicated that HDAC8 did not form complexes with Notch1 and HDAC inhibition had no effect on Notch1 acetylation. In a xenograft tumor model, the tumorigenicity of breast cancer cells was decreased by HDAC8 knockdown. These findings suggest the therapeutic potential of HDAC8 inhibition to suppress Notch1 signaling in breast cancer.

Original languageEnglish
Pages (from-to)1796-1807
Number of pages12
JournalOncotarget
Volume7
Issue number2
DOIs
Publication statusPublished - Jan 1 2016
Externally publishedYes

Fingerprint

Notch1 Receptor
Neoplastic Stem Cells
Protein Stability
Histone Deacetylase Inhibitors
Histone Deacetylases
Breast Neoplasms
Depsipeptides
Proteasome Inhibitors
Acetylation
Immunoprecipitation
Heterografts
Small Interfering RNA
Protein Isoforms
Pharmacology
Pharmaceutical Preparations
Neoplasms
Therapeutics

Keywords

  • Breast cancer
  • Cancer stem cells
  • Histone deacetylase 8
  • Histone deacetylase inhibitors
  • Notch1

ASJC Scopus subject areas

  • Oncology

Cite this

Chao, M. W., Chu, P. C., Chuang, H. C., Shen, F. H., Chou, C. C., Hsu, E. C., ... Chen, C. S. (2016). Non-epigenetic function of HDAC8 in regulating breast cancer stem cells by maintaining Notch1 protein stability. Oncotarget, 7(2), 1796-1807. https://doi.org/10.18632/oncotarget.6427

Non-epigenetic function of HDAC8 in regulating breast cancer stem cells by maintaining Notch1 protein stability. / Chao, Min Wu; Chu, Po Chen; Chuang, Hsiao Ching; Shen, Fang Hsiu; Chou, Chih Chien; Hsu, En Chi; Himmel, Lauren E.; Huang, Han Li; Tu, Huang Ju; Kulp, Samuel K.; Teng, Che Ming; Chen, Ching Shih.

In: Oncotarget, Vol. 7, No. 2, 01.01.2016, p. 1796-1807.

Research output: Contribution to journalArticle

Chao, MW, Chu, PC, Chuang, HC, Shen, FH, Chou, CC, Hsu, EC, Himmel, LE, Huang, HL, Tu, HJ, Kulp, SK, Teng, CM & Chen, CS 2016, 'Non-epigenetic function of HDAC8 in regulating breast cancer stem cells by maintaining Notch1 protein stability', Oncotarget, vol. 7, no. 2, pp. 1796-1807. https://doi.org/10.18632/oncotarget.6427
Chao, Min Wu ; Chu, Po Chen ; Chuang, Hsiao Ching ; Shen, Fang Hsiu ; Chou, Chih Chien ; Hsu, En Chi ; Himmel, Lauren E. ; Huang, Han Li ; Tu, Huang Ju ; Kulp, Samuel K. ; Teng, Che Ming ; Chen, Ching Shih. / Non-epigenetic function of HDAC8 in regulating breast cancer stem cells by maintaining Notch1 protein stability. In: Oncotarget. 2016 ; Vol. 7, No. 2. pp. 1796-1807.
@article{d85c55fef6c1497381f145384c3f4fe9,
title = "Non-epigenetic function of HDAC8 in regulating breast cancer stem cells by maintaining Notch1 protein stability",
abstract = "Here, we report a novel non-epigenetic function of histone deacetylase (HDAC) 8 in activating cancer stem cell (CSC)-like properties in breast cancer cells by enhancing the stability of Notch1 protein. The pan-HDAC inhibitors AR-42 and SAHA, and the class I HDAC inhibitor depsipeptide, suppressed mammosphere formation and other CSC markers by reducing Notch1 expression in MDA-MB-231 and SUM-159 cells. Interrogation of individual class I isoforms (HDAC1-3 and 8) using si/shRNAmediated knockdown, ectopic expression and/or pharmacological inhibition revealed HDAC8 to be the primary mediator of this drug effect. This suppression of Notch1 in response to HDAC8 inhibition was abrogated by the proteasome inhibitor MG132 and siRNA-induced silencing of Fbwx7, indicating Notch1 suppression occurred through proteasomal degradation. However, co-immunoprecipitation analysis indicated that HDAC8 did not form complexes with Notch1 and HDAC inhibition had no effect on Notch1 acetylation. In a xenograft tumor model, the tumorigenicity of breast cancer cells was decreased by HDAC8 knockdown. These findings suggest the therapeutic potential of HDAC8 inhibition to suppress Notch1 signaling in breast cancer.",
keywords = "Breast cancer, Cancer stem cells, Histone deacetylase 8, Histone deacetylase inhibitors, Notch1",
author = "Chao, {Min Wu} and Chu, {Po Chen} and Chuang, {Hsiao Ching} and Shen, {Fang Hsiu} and Chou, {Chih Chien} and Hsu, {En Chi} and Himmel, {Lauren E.} and Huang, {Han Li} and Tu, {Huang Ju} and Kulp, {Samuel K.} and Teng, {Che Ming} and Chen, {Ching Shih}",
year = "2016",
month = "1",
day = "1",
doi = "10.18632/oncotarget.6427",
language = "English",
volume = "7",
pages = "1796--1807",
journal = "Oncotarget",
issn = "1949-2553",
publisher = "Impact Journals LLC",
number = "2",

}

TY - JOUR

T1 - Non-epigenetic function of HDAC8 in regulating breast cancer stem cells by maintaining Notch1 protein stability

AU - Chao, Min Wu

AU - Chu, Po Chen

AU - Chuang, Hsiao Ching

AU - Shen, Fang Hsiu

AU - Chou, Chih Chien

AU - Hsu, En Chi

AU - Himmel, Lauren E.

AU - Huang, Han Li

AU - Tu, Huang Ju

AU - Kulp, Samuel K.

AU - Teng, Che Ming

AU - Chen, Ching Shih

PY - 2016/1/1

Y1 - 2016/1/1

N2 - Here, we report a novel non-epigenetic function of histone deacetylase (HDAC) 8 in activating cancer stem cell (CSC)-like properties in breast cancer cells by enhancing the stability of Notch1 protein. The pan-HDAC inhibitors AR-42 and SAHA, and the class I HDAC inhibitor depsipeptide, suppressed mammosphere formation and other CSC markers by reducing Notch1 expression in MDA-MB-231 and SUM-159 cells. Interrogation of individual class I isoforms (HDAC1-3 and 8) using si/shRNAmediated knockdown, ectopic expression and/or pharmacological inhibition revealed HDAC8 to be the primary mediator of this drug effect. This suppression of Notch1 in response to HDAC8 inhibition was abrogated by the proteasome inhibitor MG132 and siRNA-induced silencing of Fbwx7, indicating Notch1 suppression occurred through proteasomal degradation. However, co-immunoprecipitation analysis indicated that HDAC8 did not form complexes with Notch1 and HDAC inhibition had no effect on Notch1 acetylation. In a xenograft tumor model, the tumorigenicity of breast cancer cells was decreased by HDAC8 knockdown. These findings suggest the therapeutic potential of HDAC8 inhibition to suppress Notch1 signaling in breast cancer.

AB - Here, we report a novel non-epigenetic function of histone deacetylase (HDAC) 8 in activating cancer stem cell (CSC)-like properties in breast cancer cells by enhancing the stability of Notch1 protein. The pan-HDAC inhibitors AR-42 and SAHA, and the class I HDAC inhibitor depsipeptide, suppressed mammosphere formation and other CSC markers by reducing Notch1 expression in MDA-MB-231 and SUM-159 cells. Interrogation of individual class I isoforms (HDAC1-3 and 8) using si/shRNAmediated knockdown, ectopic expression and/or pharmacological inhibition revealed HDAC8 to be the primary mediator of this drug effect. This suppression of Notch1 in response to HDAC8 inhibition was abrogated by the proteasome inhibitor MG132 and siRNA-induced silencing of Fbwx7, indicating Notch1 suppression occurred through proteasomal degradation. However, co-immunoprecipitation analysis indicated that HDAC8 did not form complexes with Notch1 and HDAC inhibition had no effect on Notch1 acetylation. In a xenograft tumor model, the tumorigenicity of breast cancer cells was decreased by HDAC8 knockdown. These findings suggest the therapeutic potential of HDAC8 inhibition to suppress Notch1 signaling in breast cancer.

KW - Breast cancer

KW - Cancer stem cells

KW - Histone deacetylase 8

KW - Histone deacetylase inhibitors

KW - Notch1

UR - http://www.scopus.com/inward/record.url?scp=84957717703&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84957717703&partnerID=8YFLogxK

U2 - 10.18632/oncotarget.6427

DO - 10.18632/oncotarget.6427

M3 - Article

C2 - 26625202

AN - SCOPUS:84957717703

VL - 7

SP - 1796

EP - 1807

JO - Oncotarget

JF - Oncotarget

SN - 1949-2553

IS - 2

ER -